Epidemiological data indicate an explosion of type 2 diabetes cases for women after menopause. By elucidating how estrogen affects two of the hormones involved in glucose homeostasis, researchers demonstrate the value of estrogen supplementation from the onset of menopause. They also show that only one of the three estrogen receptors seems to be involved in this mechanism. This could ultimately provide more targeted therapies.